One-stage Breast Reconstruction Using Dermal Matrix/Implant Versus Two-stage Expander/Implant Procedure (AllodermRCT)
Acellular Dermal Matrix in One-Stage Breast Reconstruction: A RCT
Sponsor: Canadian Breast Cancer Foundation
Listed as NCT00956384, this NA trial focuses on Breast Cancer and remains completed. Sponsored by Canadian Breast Cancer Foundation, it has been updated 9 times since 2009, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
9 versions recorded-
Jan 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Jan 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Oct 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Jun 2018 — Oct 2018 [monthly]
Completed NA
-
Mar 2018 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Aug 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
Phase: PHASE3 → NA
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Sep 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Breast Cancer Foundation
- Tom Baker Cancer Centre
- University Health Network, Toronto
- Vancouver General Hospital
- Women's College Hospital
For direct contact, visit the study record on ClinicalTrials.gov .